3-iodobenzylguanidine has been researched along with Leukoencephalopathy Syndrome, Posterior in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eguchi, S; Hasegawa, D; Hasegawa, T; Ichihashi, Y; Kanomata, N; Narumi, S; Nozaki, T; Ono, R; Ozawa, M; Sato, T; Umehara, N; Yada, K | 1 |
| Akimoto, J; Haraoka, J; Hashimoto, R; Nakajima, N; Tsutsumi, M | 1 |
2 other study(ies) available for 3-iodobenzylguanidine and Leukoencephalopathy Syndrome, Posterior
| Article | Year |
|---|---|
Hereditary paraganglioma presenting with atypical symptoms: Case report.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Catecholamines; Child; Headache; Humans; Male; Paraganglioma; Pheochromocytoma; Polyuria; Posterior Leukoencephalopathy Syndrome; Proteinuria; Radionuclide Imaging; Weight Loss | 2021 |
Two cases of posterior reversible encephalopathy syndrome resembling brainstem glioma.
Topics: 3-Iodobenzylguanidine; Adult; Brain; Brain Stem Neoplasms; Catecholamines; Female; Glioma; Hashimoto Disease; Humans; Hypertensive Encephalopathy; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Posterior Leukoencephalopathy Syndrome; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |